These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

182 related items for PubMed ID: 30970357

  • 1. Post-Stroke Blood-Brain Barrier Disruption and Poor Functional Outcome in Patients Receiving Thrombolytic Therapy.
    Nadareishvili Z, Simpkins AN, Hitomi E, Reyes D, Leigh R.
    Cerebrovasc Dis; 2019; 47(3-4):135-142. PubMed ID: 30970357
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Identification of Reversible Disruption of the Human Blood-Brain Barrier Following Acute Ischemia.
    Simpkins AN, Dias C, Leigh R, National Institutes of Health Natural History of Stroke Investigators.
    Stroke; 2016 Sep; 47(9):2405-8. PubMed ID: 27462115
    [Abstract] [Full Text] [Related]

  • 4. Post-stroke blood-brain barrier disruption predicts poor outcome in patients enrolled in the ACTION study.
    Leigh R, Hitomi E, Hutchison RM, Elkins J.
    J Neuroimaging; 2021 Jul; 31(4):751-757. PubMed ID: 33886128
    [Abstract] [Full Text] [Related]

  • 5. Blood-brain barrier disruption is associated with increased mortality after endovascular therapy.
    Desilles JP, Rouchaud A, Labreuche J, Meseguer E, Laissy JP, Serfaty JM, Lapergue B, Klein IF, Guidoux C, Cabrejo L, Sirimarco G, Lavallée PC, Schouman-Claeys E, Amarenco P, Mazighi M.
    Neurology; 2013 Feb 26; 80(9):844-51. PubMed ID: 23365060
    [Abstract] [Full Text] [Related]

  • 6. Blood Brain Barrier Disruption in Diabetic Stroke Related to Unfavorable Outcome.
    Yu X, Xu X, Jackson A, Sun J, Huang P, Mao Y, Chen Z, Lou M, Jiang Q, Zhang M.
    Cerebrovasc Dis; 2016 Feb 26; 42(1-2):49-56. PubMed ID: 26986824
    [Abstract] [Full Text] [Related]

  • 7. Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke.
    Higashida RT, Furlan AJ, Roberts H, Tomsick T, Connors B, Barr J, Dillon W, Warach S, Broderick J, Tilley B, Sacks D, Technology Assessment Committee of the American Society of Interventional and Therapeutic Neuroradiology, Technology Assessment Committee of the Society of Interventional Radiology.
    Stroke; 2003 Aug 26; 34(8):e109-37. PubMed ID: 12869717
    [Abstract] [Full Text] [Related]

  • 8. Recombinant Tissue-Type Plasminogen Activator Study of Wake-Up Ischemic Strokes Guided by Rapid MRI.
    Guo C, Bai Q, Zhao Z, Zhang J.
    Cerebrovasc Dis; 2019 Aug 26; 48(1-2):85-90. PubMed ID: 31587000
    [Abstract] [Full Text] [Related]

  • 9. Outcome of stroke patients receiving different doses of recombinant tissue plasminogen activator.
    Ong CT, Wong YS, Wu CS, Su YH.
    Drug Des Devel Ther; 2017 Aug 26; 11():1559-1566. PubMed ID: 28572721
    [Abstract] [Full Text] [Related]

  • 10. Prognostic value of plasma HMGB1 in ischemic stroke patients with cerebral ischemia-reperfusion injury after intravenous thrombolysis.
    Wang J, Jiang Y, Zeng D, Zhou W, Hong X.
    J Stroke Cerebrovasc Dis; 2020 Sep 26; 29(9):105055. PubMed ID: 32807461
    [Abstract] [Full Text] [Related]

  • 11. Should IV Thrombolysis be given in Patients with Suspected Ischemic Stroke but Unknown Symptom Onset and Without Diffusion-Weighted Imaging Lesion? - Results of a Case-Control Study.
    Seyhan M, Mackenrodt D, Gunreben I, Müllges W, Haeusler KG, Pham M, Kleinschnitz C, Kraft P.
    J Stroke Cerebrovasc Dis; 2020 Feb 26; 29(2):104515. PubMed ID: 31786042
    [Abstract] [Full Text] [Related]

  • 12. Acute Stroke Patients With Mild-to-Moderate Pre-existing Disability Should Be Considered for Thrombolysis Treatment.
    Zhang W, Coote S, Frost T, Dewey HM, Choi PMC.
    J Stroke Cerebrovasc Dis; 2018 Oct 26; 27(10):2707-2711. PubMed ID: 30037650
    [Abstract] [Full Text] [Related]

  • 13. Effect of blood pressure on early neurological deterioration of acute ischemic stroke patients with intravenous rt-PA thrombolysis may be mediated through oxidative stress induced blood-brain barrier disruption and AQP4 upregulation.
    He Y, Yang Q, Liu H, Jiang L, Liu Q, Lian W, Huang J.
    J Stroke Cerebrovasc Dis; 2020 Aug 26; 29(8):104997. PubMed ID: 32689627
    [Abstract] [Full Text] [Related]

  • 14. Intravenous Thrombolysis Guided by Perfusion CT with Alteplase in >4.5 Hours from Stroke Onset.
    Medina-Rodriguez M, Millan-Vazquez M, Zapata-Arriaza E, Escudero I, Pardo-Galiana B, Cabezas-Rodriguez JA, Lebrato-Hernandez L, Ortega-Quintanilla J, de Albóniga-Chindurza A, Ocete-Perez RF, Jurado-Serrano J, Gonzalez-Garcia A, Cayuela A, Moniche F.
    Cerebrovasc Dis; 2020 Aug 26; 49(3):328-333. PubMed ID: 32615572
    [Abstract] [Full Text] [Related]

  • 15. Increased blood-brain barrier permeability in contralateral hemisphere predicts worse outcome in acute ischemic stroke after reperfusion therapy.
    Liu C, Yan S, Zhang R, Chen Z, Shi F, Zhou Y, Zhang M, Lou M.
    J Neurointerv Surg; 2018 Oct 26; 10(10):937-941. PubMed ID: 29352054
    [Abstract] [Full Text] [Related]

  • 16. Elevated plasma fibrinogen indicates short-term poor outcome in patients with acute ischemic stroke after intravenous thrombolysis.
    Li D, Xing C, Li Y, Zhu X.
    J Stroke Cerebrovasc Dis; 2020 Aug 26; 29(8):104991. PubMed ID: 32689615
    [Abstract] [Full Text] [Related]

  • 17. Evidence of reperfusion injury, exacerbated by thrombolytic therapy, in human focal brain ischemia using a novel imaging marker of early blood-brain barrier disruption.
    Warach S, Latour LL.
    Stroke; 2004 Nov 26; 35(11 Suppl 1):2659-61. PubMed ID: 15472105
    [Abstract] [Full Text] [Related]

  • 18. Stroke lesion volumes and outcome are not different in hemispheric stroke side treated with intravenous thrombolysis based on magnetic resonance imaging criteria.
    Golsari A, Cheng B, Sobesky J, Schellinger PD, Fiehler J, Gerloff C, Thomalla G.
    Stroke; 2015 Apr 26; 46(4):1004-8. PubMed ID: 25700285
    [Abstract] [Full Text] [Related]

  • 19. Pretreatment diffusion-weighted imaging lesion volume predicts favorable outcome after intravenous thrombolysis with tissue-type plasminogen activator in acute ischemic stroke.
    Kruetzelmann A, Köhrmann M, Sobesky J, Cheng B, Rosenkranz M, Röther J, Schellinger PD, Ringleb P, Gerloff C, Fiehler J, Thomalla G.
    Stroke; 2011 May 26; 42(5):1251-4. PubMed ID: 21415399
    [Abstract] [Full Text] [Related]

  • 20. Utility of early post-treatment single-photon emission computed tomography imaging to predict outcome in stroke patients treated with intravenous tissue plasminogen activator.
    Abumiya T, Katoh M, Moriwaki T, Yoshino M, Aoki T, Imamura H, Aida T, Scichinohe H, Nakayama N, Kazumata K, Houkin K.
    J Stroke Cerebrovasc Dis; 2014 May 26; 23(5):896-901. PubMed ID: 24045082
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.